David H. Mack - Feb 10, 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 03:12 PM
Previous filing
Dec 16, 2021
Next filing
Mar 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Feb 10, 2022 Common Stock 250K $16.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.